James Emmett Young - 27 Jan 2025 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role: Chief Financial Officer
Signature: /s/ James Emmett Young
Issuer symbol: TLSI
Transactions as of: 27 Jan 2025
Net transactions value: +$129,600
Form type: 4
Filing time: 29 Jan 2025, 18:03:45 UTC
Previous filing: 15 Jan 2025
Next filing: 06 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TLSI	Common Stock	Award	$0	+12,500	+135%	$0.000000	21,726	27 Jan 2025	Direct	F1
transaction	TLSI	Common Stock	Purchase	$129,600	+24,000		$5.40	24,000	27 Jan 2025	By Kathleen A. Young Living Trust	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TLSI	Employee Stock Option (right to buy)	Award	$0	+75,000		$0.000000	75,000	27 Jan 2025	Common Stock	75,000	$5.30	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on January 1, 2025, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
F2	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.11 to $5.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3	The Reporting Person is the sole trustee of Kathleen A. Young Living Trust.
F4	One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of January 1, 2025 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date.